A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2011
12/08/2011	WO2011153502A2 Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
12/08/2011	WO2011153460A2 Therapeutic amoeba and uses thereof
12/08/2011	WO2011153351A2 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
12/08/2011	WO2011153319A1 C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
12/08/2011	WO2011153315A1 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
12/08/2011	WO2011152508A1 Optically active dibenzylamine derivative, and manufacturing method for same
12/08/2011	WO2011152485A1 Novel 4,5-fused pyrimidine derivative
12/08/2011	WO2011151760A2 Vaccine formulations
12/08/2011	WO2011151733A2 Fexofenadine-based composition and preparation process therefor
12/08/2011	WO2011151701A1 6 - methyl - 4 - phenyl - 5 - ( phenyl or cycloalkyl) carbamoyl - 1,2,3, 4 - tetrahydropyrimidin- 2 - one derivatives as antitubercular agents
12/08/2011	WO2011151652A1 Benzodiazepine compounds useful for the treatment of hepatitis c
12/08/2011	WO2011151651A1 Benzodiazepine compounds useful for the treatment of hepatitis c
12/08/2011	WO2011151621A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011	WO2011151620A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011	WO2011151619A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011	WO2011151617A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011	WO2011151499A1 Use of an iminosugar as an inhibitor of epithelial cell adhesion
12/08/2011	WO2011151330A1 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases
12/08/2011	WO2011151320A1 Nitroimidazole derivatives
12/08/2011	WO2011150745A1 Mycobacterium tuberculosis ag85ab chimeric gene vaccine, its preparation method and application
12/08/2011	WO2011150679A1 Crystalline form of carbapenem derivative or its hydrates and preparation methods and uses thereof
12/08/2011	WO2011150566A1 Novel dna vaccine adjuvant
12/08/2011	WO2011150493A1 Mitochondrial penetrating peptides as carriers for antimicrobials
12/08/2011	WO2011150481A1 Nanoparticulate composition containing antibiotics for intramammary administration in animals
12/08/2011	WO2011150441A1 Medical aerosol formulation comprising ribavirin
12/08/2011	WO2011041350A3 Xenotropic mulv-related virus (xmrv) compositions and methods of use
12/08/2011	US20110302675 Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts
12/08/2011	US20110301241 New halo active aromatic sulfonamide organic compounds and uses therefor
12/08/2011	US20110301220 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301219 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301216 Anticancer and antimicrobial compounds from antarctic extremophilic microorgansims
12/08/2011	US20110301215 Inhibitors of plasma kallikrein
12/08/2011	US20110301208 Viral and fungal inhibitors
12/08/2011	US20110301205 Isoxazole derivatives for use as fungicides
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301154 Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anticancer activity
12/08/2011	US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011	US20110301139 Pharmaceutical compositions of cefixime
12/08/2011	US20110301133 Compositions of protein receptor tyrosine kinase inhibitors
12/08/2011	US20110301132 Methods of treating urethritis and related infections using fusidic acid
12/08/2011	US20110301131 Drug Delivery Implants and Processes for Their Preparation
12/08/2011	US20110301129 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
12/08/2011	US20110301127 Methods of reducing microbial resistance to drugs
12/08/2011	US20110301099 Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301078 Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems
12/08/2011	US20110301077 Method for production of lactoferrin
12/08/2011	US20110301076 Antimicrobial compounds
12/08/2011	US20110300235 Gallium-containing sealant for medical use
12/08/2011	US20110300229 Treating or preventing rotavirus infection
12/08/2011	US20110300206 Vaccines against chlamydial infection
12/08/2011	US20110300205 Self replicating rna molecules and uses thereof
12/08/2011	US20110300202 Medical item for long term durg release
12/08/2011	US20110300199 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
12/08/2011	US20110300189 Antimicrobial colloidal silver products and method of making same
12/08/2011	US20110300185 Immunogenic escherichia coli heat stable enterotoxin
12/08/2011	US20110300183 Method of preparing adenosine-resistant anti-tumor t lymphocytes for adoptive immunotherapy
12/08/2011	US20110300181 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
12/08/2011	US20110300180 plant-derived vaccines against respiratory syncytial virus
12/08/2011	US20110300179 Novel Compositions and Uses Thereof
12/08/2011	US20110300178 Hpv types and variants associated with cervical cancer and the uses thereof
12/08/2011	US20110300177 Triterpene saponins, methods of synthesis, and uses thereof
12/08/2011	US20110300171 Factor h binding protein immunogens
12/08/2011	US20110300170 Hcv vaccines
12/08/2011	US20110300169 Pharmaceutical composition comprising an antigen
12/08/2011	US20110300168 Compositions and methods for inducing an immune response against influenza antigens
12/08/2011	US20110300167 Cxcr5 receptor compounds
12/08/2011	US20110300155 Modulating xrn2
12/08/2011	US20110300149 Ljungan virus
12/08/2011	US20110300129 Systems and methods for enhancing vaccine efficacy
12/08/2011	US20110300109 Compositions and methods for treating cancer
12/08/2011	US20110300106 Therapeutic amoeba and uses thereof
12/08/2011	US20110300105 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
12/08/2011	US20110300104 Hepatitis c virus inhibitors
12/08/2011	US20110300103 Heterocyclic antiviral compounds
12/08/2011	US20110300101 Methods for treating viral infection using IL-28 and IL-29 Cysteine mutants
12/08/2011	US20110300083 Personal care formulations containing alkyl ketal esters and methods of manufacture
12/08/2011	US20110300069 Methods of Using Labeled Ligands Having Human CD4 Specificity
12/08/2011	DE10241495B4 Antimikrobielle Alkalisilicat-Glaskeramik, Glaskeramikpulver, Verfahren zu dessen Herstellung und Verwendung Antimicrobial alkali silicate glass ceramic, glass ceramic powder, a process for its preparation and use
12/08/2011	DE102011013341A1 New water-soluble or water swellable polymer comprising amidoalkyl sulfonic-, alkylamide- and crosslinked alkyleneoxy-repeating units, useful e.g. as a thickener, emulsifier, sensory additives, solubilizer, dispersant and lubricant
12/08/2011	CA2801491A1 C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
12/08/2011	CA2801487A1 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
12/08/2011	CA2801449A1 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases
12/08/2011	CA2801417A1 Optically active dibenzylamine derivative, and method for preparing thereof
12/08/2011	CA2801274A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011	CA2800824A1 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
12/08/2011	CA2800730A1 Mitochondrial penetrating peptides as carriers for antimicrobials
12/08/2011	CA2800531A1 Humanized monoclonal antibodies and methods of use
12/08/2011	CA2799747A1 Vaccine formulations comprising 2-phenoxyethanol
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP2392587A1 Peptide sequences and compositions
12/07/2011	EP2392580A1 2'-fluoronucleosides
12/07/2011	EP2392351A1 Hiv replication inhibitor, and use thereof
12/07/2011	EP2392343A1 Antimicrobial composition and uses thereof
12/07/2011	EP2392326A1 Silibinin component for the treatment of hepatitis
12/07/2011	EP2391649A1 Tslp promotes immune evasion and persistence of viruses
12/07/2011	EP2391371A2 A high molecular weight polysaccharide that binds and inhibits virus
12/07/2011	EP2391344A1 Compositions for nail and skin treatment
12/07/2011	EP2391212A1 Bridged compounds as hiv integrase inhibitors

1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 1798